AI Ambition in the Life Sciences Is Fast Outpacing Data Foundations
AI is reshaping life sciences, but uneven data maturity could limit its impact. Explore the key findings shaping the industry’s path to AI at scale.
Explore forward-thinking perspectives from our industry experts.
The State of Data 2026 gives you a clear, data-backed view of how enterprises are scaling AI and where many are falling behind. Powered by IBM Institute for Business Value research, it helps you understand what’s working, what’s risky, and how to approach agentic AI, governance, and hybrid architecture with confidence this year.